3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome: Concerns regarding presentation of previous studies
- PMID: 29406572
- DOI: 10.1002/mus.26091
3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome: Concerns regarding presentation of previous studies
Comment in
-
Reply.Muscle Nerve. 2018 May;57(5):E130-E131. doi: 10.1002/mus.26089. Epub 2018 Mar 1. Muscle Nerve. 2018. PMID: 29406616 No abstract available.
Comment on
-
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.Muscle Nerve. 2018 Apr;57(4):561-568. doi: 10.1002/mus.26052. Epub 2018 Feb 2. Muscle Nerve. 2018. PMID: 29280483 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources